Literature DB >> 22683498

Empowering biotechnology in southern Africa: establishment of a robust transformation platform for the production of transgenic industry-preferred cassava.

C C Chetty1, C B Rossin, W Gruissem, H Vanderschuren, M E C Rey.   

Abstract

Knowledge and technology transfer to African laboratories and farmers is an important objective for achieving food security and sustainable crop production on the sub-Saharan African continent. Cassava (Manihot esculenta Crantz) is a vital source of calories for more than a billion people in developing countries, and its potential industrial use for starch and bioethanol in the tropics is increasingly being recognized. However, cassava production remains constrained by the susceptibility of the crop to several biotic and abiotic stresses. For more than a decade, biotechnology has been considered an attractive tool to improve cassava as it substantially circumvents the limitations of traditional breeding, which is particularly time-consuming and tedious because of the high heterozygosity of the crop. A major constraint to the development of biotechnological approaches for cassava improvement has been the lack of an efficient and robust transformation and regeneration system. Despite some success achieved in genetic modification of the model cassava cultivar Tropical Manihot Series (TMS), TMS 60444, in some European and U.S. laboratories, the lack of a reproducible and robust protocol has not allowed the establishment of a routine transformation system in sub-Saharan Africa. In this study, we optimized a robust and efficient protocol developed at ETH Zurich to successfully establish transformation of a commercially cultivated South African landrace, T200, and compared this with the benchmark model cultivar TMS 60444. Results from our study demonstrated high transformation rates for both T200 (23 transgenic lines from 100 friable embryogenic callus (FEC) clusters) compared with TMS 60444 (32 transgenic lines from 100 FEC clusters). The success in transforming landraces or farmer-preferred cultivars has been limited, and the high transformation rate of an industry-preferred landrace in this study is encouraging for a feasible transformation program for cassava improvement in South Africa (SA), which can potentially be extended to other countries in southern Africa. The successful establishment of a robust cassava transformation and regeneration system in SA demonstrates the relevance of technology transfer to sub-Saharan Africa and highlights the importance of developing suitable and reliable techniques before their transfer to laboratories offering less optimal conditions.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22683498     DOI: 10.1016/j.nbt.2012.04.006

Source DB:  PubMed          Journal:  N Biotechnol        ISSN: 1871-6784            Impact factor:   5.079


  14 in total

1.  Strengthening African R&D through effective transfer of tropical crop biotech to African institutions.

Authors:  Hervé Vanderschuren
Journal:  Nat Biotechnol       Date:  2012-12       Impact factor: 54.908

2.  Robust transformation procedure for the production of transgenic farmer-preferred cassava landraces.

Authors:  Ima M Zainuddin; Kim Schlegel; Wilhelm Gruissem; Hervé Vanderschuren
Journal:  Plant Methods       Date:  2012-07-11       Impact factor: 4.993

3.  Factors influencing somatic embryogenesis, regeneration, and Agrobacterium-mediated transformation of cassava (Manihot esculenta Crantz) cultivar TME14.

Authors:  Evans N Nyaboga; Joshua M Njiru; Leena Tripathi
Journal:  Front Plant Sci       Date:  2015-06-10       Impact factor: 5.753

4.  Unlocking the potential of tropical root crop biotechnology in east Africa by establishing a genetic transformation platform for local farmer-preferred cassava cultivars.

Authors:  Evans Nyaboga; Joshua Njiru; Edward Nguu; Wilhelm Gruissem; Herve Vanderschuren; Leena Tripathi
Journal:  Front Plant Sci       Date:  2013-12-24       Impact factor: 5.753

Review 5.  The potential of using biotechnology to improve cassava: a review.

Authors:  Paul Chavarriaga-Aguirre; Alejandro Brand; Adriana Medina; Mónica Prías; Roosevelt Escobar; Juan Martinez; Paula Díaz; Camilo López; Willy M Roca; Joe Tohme
Journal:  In Vitro Cell Dev Biol Plant       Date:  2016-08-12       Impact factor: 2.252

6.  Formation of friable embryogenic callus in cassava is enhanced under conditions of reduced nitrate, potassium and phosphate.

Authors:  Yoshinori Utsumi; Chikako Utsumi; Maho Tanaka; Vu The Ha; Akihiro Matsui; Satoshi Takahashi; Motoaki Seki
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

7.  Accelerated ex situ breeding of GBSS- and PTST1-edited cassava for modified starch.

Authors:  Simon E Bull; David Seung; Christelle Chanez; Devang Mehta; Joel-Elias Kuon; Elisabeth Truernit; Anton Hochmuth; Irene Zurkirchen; Samuel C Zeeman; Wilhelm Gruissem; Hervé Vanderschuren
Journal:  Sci Adv       Date:  2018-09-05       Impact factor: 14.136

8.  Cassava geminivirus agroclones for virus-induced gene silencing in cassava leaves and roots.

Authors:  Ezequiel Matias Lentz; Joel-Elias Kuon; Adrian Alder; Nathalie Mangel; Ima M Zainuddin; Emily Jane McCallum; Ravi Bodampalli Anjanappa; Wilhelm Gruissem; Hervé Vanderschuren
Journal:  Plant Methods       Date:  2018-08-27       Impact factor: 4.993

9.  Transition from somatic embryo to friable embryogenic callus in cassava: dynamic changes in cellular structure, physiological status, and gene expression profiles.

Authors:  Qiuxiang Ma; Wenzhi Zhou; Peng Zhang
Journal:  Front Plant Sci       Date:  2015-10-06       Impact factor: 5.753

10.  Novel Bioengineered Cassava Expressing an Archaeal Starch Degradation System and a Bacterial ADP-Glucose Pyrophosphorylase for Starch Self-Digestibility and Yield Increase.

Authors:  Ayalew Ligaba-Osena; Jenna Jones; Emmanuel Donkor; Sanjeev Chandrayan; Farris Pole; Chang-Hao Wu; Claire Vieille; Michael W W Adams; Bertrand B Hankoua
Journal:  Front Plant Sci       Date:  2018-02-26       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.